Alliance bids to check diabetes surge in UAE
Dubai, September 27, 2011
A newly formed alliance of healthcare companies aims to educate and raise awareness about diabetes and provide products to help diagnose, treat and manage the symptoms of the disease in the UAE.
Supported by organizations such as MPC, Servier, Astrazeneca, Bristol-Myers Squibb, Nestlé Health Science, Merck Serono, Lifescan, and Medtronic, Decide is an innovative and unique initiative of major healthcare companies in the UAE that recognizes a better education and greater awareness of the condition could lead to the successful prevention and management of diabetes.
“What excites us about Decide is that for the first time, there is a true understanding and alignment from all stakeholders as to what the problem is, and more importantly what we can all do to help,” says Jan Felton, managing director of MPC.
“The problem is not diagnosis or even how to treat diabetes, it is educating the patients and most importantly, helping them decide to do the right thing and to live life to the full with diabetes," he added.
As an alliance, Decide has a greater voice and further reach than a single concerned entity, and by pooling their resources together, Decide is able to reach out to a greater number of people and change how society behaves and treats diabetes.
Decide conveys the “Live Life To The Full With Diabetes” message through an all-round strategy of providing support not only to diabetics and their immediate carers, but also to professional healthcare practitioners such as doctors, dieticians and health authorities.
This holistic approach is further supported by a web-portal (decidecommunity.com) that will not only disseminate up-to-date information but also act as a platform and forum for diabetes. – TradeArabia News Service